- ONEM Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
1life Healthcare (ONEM) Financial statements
Company Profile
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | ||
---|---|---|---|---|---|
Total Revenue | |||||
Cost of Revenue | |||||
Gross Profit | |||||
Gross Profit Margin (%) | |||||
R&D Expense | |||||
SG&A Expense | |||||
Total Operating Expenses | |||||
Operating Income or Loss | |||||
Operating Margin (%) | |||||
Interest Expense | |||||
Total Other Income/Expenses | |||||
Income Before Tax | |||||
Income Tax Expense | |||||
Income from Continuing Ops. | |||||
Net Income | |||||
Net Profit Margin (%) | |||||
Net Income Available to Common Shareholders | |||||
Basic EPS | |||||
Diluted EPS | |||||
Basic Average Shares | |||||
Diluted Average Shares |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||
Cost of Revenue | ||||||||||||||
Gross Profit | ||||||||||||||
Gross Profit Margin (%) | ||||||||||||||
R&D Expense | ||||||||||||||
SG&A Expense | ||||||||||||||
Total Operating Expenses | ||||||||||||||
Operating Income or Loss | ||||||||||||||
Operating Margin (%) | ||||||||||||||
Interest Expense | ||||||||||||||
Total Other Income/Expenses | ||||||||||||||
Income Before Tax | ||||||||||||||
Income Tax Expense | ||||||||||||||
Income from Continuing Ops. | ||||||||||||||
Net Income | ||||||||||||||
Net Profit Margin (%) | ||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||
Basic EPS | ||||||||||||||
Diluted EPS | ||||||||||||||
Basic Average Shares | ||||||||||||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | ||
---|---|---|---|---|---|
Current Assets | |||||
Cash & Cash Equivalents | |||||
Marketable Securities | |||||
Receivables | |||||
Inventories | |||||
Other Current Assets | |||||
Total Current Assets | |||||
Non-Current Assets | |||||
Marketable Securities | |||||
PPE Net | |||||
Intangibles inc. Goodwill | |||||
Other Non-Current Assets | |||||
Total Non-Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Accounts Payable | |||||
Deferred Revenues | |||||
Debt, Current | |||||
Accrued Liabilities | |||||
Other Current Liabilities | |||||
Total Current Liabilities | |||||
Non-Current Liabilities | |||||
Deferred Revenues | |||||
Debt, Non-Current | |||||
Other Non-Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Total Liabilities | |||||
Shareholders' Equity | |||||
Common Stock | |||||
Additional Paid-In Capital | |||||
Retained Earnings | |||||
Other Shareholders' Equity | |||||
Total Shareholders' Equity | |||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||
Cash & Cash Equivalents | ||||||||||||||
Marketable Securities | ||||||||||||||
Receivables | ||||||||||||||
Inventories | ||||||||||||||
Other Current Assets | ||||||||||||||
Total Current Assets | ||||||||||||||
Non-Current Assets | ||||||||||||||
Marketable Securities | ||||||||||||||
PPE Net | ||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||
Other Non-Current Assets | ||||||||||||||
Total Non-Current Assets | ||||||||||||||
Total Assets | ||||||||||||||
Current Liabilities | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Current | ||||||||||||||
Accrued Liabilities | ||||||||||||||
Other Current Liabilities | ||||||||||||||
Total Current Liabilities | ||||||||||||||
Non-Current Liabilities | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Non-Current | ||||||||||||||
Other Non-Current Liabilities | ||||||||||||||
Total Non-Current Liabilities | ||||||||||||||
Total Liabilities | ||||||||||||||
Shareholders' Equity | ||||||||||||||
Common Stock | ||||||||||||||
Additional Paid-In Capital | ||||||||||||||
Retained Earnings | ||||||||||||||
Other Shareholders' Equity | ||||||||||||||
Total Shareholders' Equity | ||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | ||
---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||
Net Income | |||||
Depreciation & Amortization | |||||
Deferred Income Taxes | |||||
Stock Based Compensation | |||||
Accounts Receivable | |||||
Inventory | |||||
Accounts Payable | |||||
Deferred Revenue | |||||
Other Non-Cash | |||||
Operating Cash Flow | |||||
Cash Flows from Investing Activities | |||||
PPE Investments | |||||
Net Acquisitions | |||||
Purchase of Investments | |||||
Sale of Investments | |||||
Other Investing Activity | |||||
Investing Cash Flow | |||||
Cash Flows from Financing Activities | |||||
Debt Issued | |||||
Proceeds from Debt Repayment | |||||
Debt Repayment | |||||
Proceeds from Sale of Equity | |||||
Equity Repurchased | |||||
Dividend Paid | |||||
Other Financing Activity | |||||
Financing Cash Flow | |||||
Cash Position | |||||
Beginning Cash Position | |||||
End Cash Position | |||||
Change in Cash | |||||
Free Cash Flow | |||||
Operating Cash Flow | |||||
Capital Expenditure | |||||
Free Cash Flow |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||
Net Income | ||||||||||||||
Depreciation & Amortization | ||||||||||||||
Deferred Income Taxes | ||||||||||||||
Stock Based Compensation | ||||||||||||||
Accounts Receivable | ||||||||||||||
Inventory | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenue | ||||||||||||||
Other Non-Cash | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||
PPE Investments | ||||||||||||||
Net Acquisitions | ||||||||||||||
Purchase of Investments | ||||||||||||||
Sale of Investments | ||||||||||||||
Other Investing Activity | ||||||||||||||
Investing Cash Flow | ||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||
Debt Issued | ||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||
Debt Repayment | ||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||
Equity Repurchased | ||||||||||||||
Dividend Paid | ||||||||||||||
Other Financing Activity | ||||||||||||||
Financing Cash Flow | ||||||||||||||
Cash Position | ||||||||||||||
Beginning Cash Position | ||||||||||||||
End Cash Position | ||||||||||||||
Change in Cash | ||||||||||||||
Free Cash Flow | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Capital Expenditure | ||||||||||||||
Free Cash Flow |